Cross Country Healthcare Statistics
Total Valuation
CCRN has a market cap or net worth of $335.42 million. The enterprise value is $276.47 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CCRN has 32.92 million shares outstanding. The number of shares has decreased by -5.89% in one year.
| Current Share Class | 32.92M |
| Shares Outstanding | 32.92M |
| Shares Change (YoY) | -5.89% |
| Shares Change (QoQ) | -2.66% |
| Owned by Insiders (%) | 6.33% |
| Owned by Institutions (%) | 102.63% |
| Float | 30.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.12 |
| PS Ratio | 0.24 |
| Forward PS | 0.23 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | 3.40 |
| P/OCF Ratio | 3.11 |
| PEG Ratio | 2.11 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.90, with an EV/FCF ratio of 2.80.
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | 8.90 |
| EV / EBIT | 20.91 |
| EV / FCF | 2.80 |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.79 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.04 |
| Interest Coverage | 6.10 |
Financial Efficiency
Return on equity (ROE) is -0.39% and return on invested capital (ROIC) is 1.83%.
| Return on Equity (ROE) | -0.39% |
| Return on Assets (ROA) | 1.27% |
| Return on Capital (ROIC) | 1.83% |
| Revenue Per Employee | $110,281 |
| Profits Per Employee | -$134 |
| Employee Count | 13,131 |
| Asset Turnover | 2.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCRN has paid $2.25 million in taxes.
| Income Tax | 2.25M |
| Effective Tax Rate | 463.92% |
Stock Price Statistics
The stock price has decreased by -50.20% in the last 52 weeks. The beta is 0.65, so CCRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -50.20% |
| 50-Day Moving Average | 12.31 |
| 200-Day Moving Average | 15.20 |
| Relative Strength Index (RSI) | 37.80 |
| Average Volume (20 Days) | 613,918 |
Short Selling Information
The latest short interest is 2.87 million, so 8.73% of the outstanding shares have been sold short.
| Short Interest | 2.87M |
| Short Previous Month | 3.11M |
| Short % of Shares Out | 8.73% |
| Short % of Float | 9.33% |
| Short Ratio (days to cover) | 2.69 |
Income Statement
In the last 12 months, CCRN had revenue of $1.45 billion and -$1.77 million in losses. Loss per share was -$0.05.
| Revenue | 1.45B |
| Gross Profit | 302.75M |
| Operating Income | 13.22M |
| Pretax Income | 16.60M |
| Net Income | -1.77M |
| EBITDA | 31.05M |
| EBIT | 13.22M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $64.02 million in cash and $4.41 million in debt, giving a net cash position of $59.61 million or $1.81 per share.
| Cash & Cash Equivalents | 64.02M |
| Total Debt | 4.41M |
| Net Cash | 59.61M |
| Net Cash Per Share | $1.81 |
| Equity (Book Value) | 424.69M |
| Book Value Per Share | 13.04 |
| Working Capital | 215.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $107.96 million and capital expenditures -$9.06 million, giving a free cash flow of $98.90 million.
| Operating Cash Flow | 107.96M |
| Capital Expenditures | -9.06M |
| Free Cash Flow | 98.90M |
| FCF Per Share | $3.00 |
Full Cash Flow StatementMargins
Gross margin is 20.91%, with operating and profit margins of 0.91% and -0.12%.
| Gross Margin | 20.91% |
| Operating Margin | 0.91% |
| Pretax Margin | 0.03% |
| Profit Margin | -0.12% |
| EBITDA Margin | 2.14% |
| EBIT Margin | 0.91% |
| FCF Margin | 10.12% |
Dividends & Yields
CCRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.89% |
| Shareholder Yield | 5.89% |
| Earnings Yield | -0.53% |
| FCF Yield | 29.43% |
Analyst Forecast
The average price target for CCRN is $18.50, which is 81.55% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.50 |
| Price Target Difference | 81.55% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCRN has an Altman Z-Score of 5.64 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.64 |
| Piotroski F-Score | 4 |